ExLibris header image
SFX Logo
Title: Genomic hallmarks of localized, non-indolent prostate cancer
Source:

Nature [0028-0836] Fraser, Michael yr:2017


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Brody, H. "PROSTATE CANCER." Nature 528.7582 (2015): 117-117. Link to Full Text for this item Link to SFX for this item
2. Tomlins, A. "Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer." Science 310.5748 (2005): 644-648. Link to SFX for this item
3. Kumar, A. "Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer." Nature Medicine 22.4 (2016): 369-378. Link to SFX for this item
4. Sandberg, R. "How to Analyze Gene Expression Using RNA-Sequencing Data." Methods in molecular biology 802: 259-274. Link to SFX for this item
5. Pfeiffer, Minja J. "Stem Cell Characteristics in Prostate Cancer Cell Lines." European urology 57.2 (2009): 246-255. Link to SFX for this item
6. Smith, I. "Prostate cancer." Nursing standard 22.18 (2007): 59-60. Link to SFX for this item
7. damber, Gerhardt e. "prostate cancer." The lancet oncology 387.10013 (2008): 1710-1721. Link to SFX for this item
8. Aus, G. "Prostate cancer." Lancet, The 371.9625 (2008): 1710-21. Link to SFX for this item
9. Hodson, R. "Prostate cancer: 4 big questions." Nature 528.7582 (2015). Link to Full Text for this item Link to SFX for this item
10. Isaacs, John T. "Prostate Cancer Takes Nerve." Science 341.6142 (2013): 134-135. Link to SFX for this item
11. Marx, J. "Medicine. Fused genes may help explain the origins of prostate cancer." Science 310.5748 (2005): 603-603. Link to SFX for this item
12. Tomlins, David S J. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer." Nature 448.7153 (2007): 595-9. Link to Full Text for this item Link to SFX for this item
13. Thompson, J. "A Novel, Spontaneously Immortalized, Human Prostate Cancer Cell Line, Bob, Offers a Unique Model for Pre-Clinical Prostate Cancer Studies." The Prostate 69.14 (2009): 1507-1520. Link to Full Text for this item Link to SFX for this item
14. Iljin, K. "TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming." Cancer research 66.21 (2006): 10242-6. Link to SFX for this item
15. Wang, J. "Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate Cancer." Cancer research 66.17 (2006): 8347-51. Link to SFX for this item
16. Perner, S. "TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion." The American journal of surgical pathology 31.6 (2007): 882-888. Link to SFX for this item
17. Tomlins, Scott A. "The mutational landscape of lethal castration-resistant prostate cancer." Nature 487.7406 (2012): 239-243. Link to Full Text for this item Link to SFX for this item
18. Schmitt, Michael W. "The influence of subclonal resistance mutations on targeted cancer therapy." Nature Reviews Clinical Oncology 13.6 (2015): 335-347. Link to SFX for this item
19. van Walraven, C. "Competing risk bias was common in Kaplan–Meier risk estimates published in prominent medical journals." Journal of clinical epidemiology 69 (2016): 170-4294967295. Link to SFX for this item
20. Blainey, P. "Points of Significance: Replication." Nature Methods 11.9 (2014): 879-880. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.